tagrisso
astrazeneca ab - osimertinib mesilate - carcinom, pulmonar non-celulă mică - alte medicamente antineoplazice, inhibitori de proteinkinază - tagrisso as monotherapy is indicated for:- the adjuvant treatment after complete tumour resection in adult patients with stage ib-iiia non-small cell lung cancer (nsclc) whose tumours have epidermal growth factor receptor (egfr) exon 19 deletions or exon 21 (l858r) substitution mutations- the first-line treatment of adult patients nsclc with activating egfr mutations. - the treatment of adult patients with locally advanced or metastatic egfr t790m mutation-positive nsclc. tagrisso as monotherapy is indicated for:- the adjuvant treatment after complete tumour resection in adult patients with stage ib-iiia non-small cell lung cancer (nsclc) whose tumours have epidermal growth factor receptor (egfr) exon 19 deletions or exon 21 (l858r) substitution mutations. - the first-line treatment of adult patients with locally advanced or metastatic nsclc with activating egfr mutations. - the treatment of adult patients with locally advanced or metastatic egfr t790m mutation-positive nsclc.
magrilan 20 mg
medochemie ltd. - cipru - fluoxetinum - caps. - 20mg - antidepresive inhibitori selectivi ai recaptarii serotoninei
humagrip
lab. urgo - franta - combinatii - compr. + caps. - decongestionante nazale de uz sistemic simpatomimetice
humagrip
laboratoires urgo - franta - combinatii - compr. + caps. - decongestionante nazale de uz sistemic simpatomimetice
magrilan capsule 20 mg
medochemie ltd - fluoxetinum - capsule - 20 mg
magrilan 20 mg capsule
medochemie ltd - fluoxetinum - capsule - 20 mg
tagrisso 80 mg comprimate filmate
astrazeneca ab - osimertinibum - comprimate filmate - 80 mg
tagrisso 40 mg comprimate filmate
astrazeneca ab - osimertinibum - comprimate filmate - 40 mg
maggots pulbere
belgagri, belgia - ciromazină - pulbere - насекомых-
strong pasta
belgagri, belgia - brodifacoum - raticid